Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats.

Fernández-Varo G, Oró D, Cable EE, Reichenbach V, Carvajal S, de la Presa BG, Wiśniewski K, Ginés P, Harris G, Jiménez W.

Hepatology. 2016 Jan;63(1):207-16. doi: 10.1002/hep.28250. Epub 2015 Nov 4.

PMID:
26403564
2.

A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis.

Gómez-Galeno JE, Dang Q, Nguyen TH, Boyer SH, Grote MP, Sun Z, Chen M, Craigo WA, van Poelje PD, MacKenna DA, Cable EE, Rolzin PA, Finn PD, Chi B, Linemeyer DL, Hecker SJ, Erion MD.

ACS Med Chem Lett. 2010 Aug 30;1(9):478-82. doi: 10.1021/ml100143q. eCollection 2010 Dec 9.

3.

Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys.

Ito BR, Zhang BH, Cable EE, Song X, Fujitaki JM, MacKenna DA, Wilker CE, Chi B, van Poelje PD, Linemeyer DL, Erion MD.

Br J Pharmacol. 2009 Feb;156(3):454-65. doi: 10.1111/j.1750-3639.2009.00038.x. Epub 2009 Jan 22.

4.

Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.

Cable EE, Finn PD, Stebbins JW, Hou J, Ito BR, van Poelje PD, Linemeyer DL, Erion MD.

Hepatology. 2009 Feb;49(2):407-17. doi: 10.1002/hep.22572.

PMID:
19072834
5.

Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs.

Boyer SH, Jiang H, Jacintho JD, Reddy MV, Li H, Li W, Godwin JL, Schulz WG, Cable EE, Hou J, Wu R, Fujitaki JM, Hecker SJ, Erion MD.

J Med Chem. 2008 Nov 27;51(22):7075-93. doi: 10.1021/jm800824d.

PMID:
18975928
6.

Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonist.

Fujitaki JM, Cable EE, Ito BR, Zhang BH, Hou J, Yang C, Bullough DA, Ferrero JL, van Poelje PD, Linemeyer DL, Erion MD.

Drug Metab Dispos. 2008 Nov;36(11):2393-403. doi: 10.1124/dmd.108.021642. Epub 2008 Aug 14.

PMID:
18703645
7.

Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Erion MD, Cable EE, Ito BR, Jiang H, Fujitaki JM, Finn PD, Zhang BH, Hou J, Boyer SH, van Poelje PD, Linemeyer DL.

Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15490-5. Epub 2007 Sep 18.

8.

Role of paracellular junction complexes in baculovirus-mediated gene transfer to nondividing rat hepatocytes.

Bilello JP, Cable EE, Myers RL, Isom HC.

Gene Ther. 2003 May;10(9):733-49.

PMID:
12704412
9.
10.

Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assay.

Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Cable EE, Isom HC.

Antimicrob Agents Chemother. 2003 Jan;47(1):324-36.

14.

Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.

Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, Rijcken TH, Stark DD.

Radiology. 1999 Jul;212(1):227-34.

PMID:
10405746
15.

Gamma delta intraepithelial lymphocytes drive tumor necrosis factor-alpha responsiveness to intestinal iron challenge: relevance to hemochromatosis.

Ten Elshof AE, Brittenham GM, Chorney KA, Page MJ, Gerhard G, Cable EE, Chorney MJ.

Immunol Rev. 1999 Feb;167:223-32.

PMID:
10319264
19.

Mechanism of induction of heme oxygenase by metalloporphyrins in primary chick embryo liver cells: evidence against a stress-mediated response.

Cable EE, Gildemeister OS, Pepe JA, Lambrecht RW, Bonkovsky HL.

Mol Cell Biochem. 1997 Apr;169(1-2):13-20.

PMID:
9089626
20.

Hepatic 5-aminolevulinic acid synthase mRNA stability is modulated by inhibitors of heme biosynthesis and by metalloporphyrins.

Cable EE, Gildemeister OS, Pepe JA, Donohue SE, Lambrecht RW, Bonkovsky HL.

Eur J Biochem. 1996 Aug 15;240(1):112-7.

21.
22.

Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.

Barton AL, Banner BF, Cable EE, Bonkovsky HL.

Am J Clin Pathol. 1995 Apr;103(4):419-24. Erratum in: Am J Clin Pathol 1995 Aug;104(2):232.

PMID:
7537017
23.

Tissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase.

Russo SM, Pepe JA, Donohue S, Cable EE, Lambrecht RW, Bonkovsky HL.

J Pharmacol Exp Ther. 1995 Feb;272(2):766-74.

PMID:
7853192
24.
25.
26.

Repression of ALA synthase by heme and zinc-mesoporphyrin in a chick embryo liver cell culture model of acute porphyria.

Russo SM, Pepe JA, Cable EE, Lambrecht RW, Bonkovsky HL.

Eur J Clin Invest. 1994 Jun;24(6):406-15.

PMID:
7957494
27.

Induction of heme oxygenase in intestinal epithelial cells: studies in Caco-2 cell cultures.

Cable JW, Cable EE, Bonkovsky HL.

Mol Cell Biochem. 1993 Dec 8;129(1):93-8.

PMID:
8177232
28.

Purifying nascent mRNA from nuclear run-on assays using guanidinium isothiocyanate.

Srivastva KK, Cable EE, Bonkovsky HL.

Biotechniques. 1993 Aug;15(2):226-7. No abstract available.

PMID:
8373584
29.
30.
31.

Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh).

Bonkovsky HL, Cable EE, Cable JW, Donohue SE, White EC, Greene YJ, Lambrecht RW, Srivastava KK, Arnold WN.

Biochem Pharmacol. 1992 Jun 9;43(11):2359-68.

PMID:
1610401
32.

Synergistic induction of delta-aminolevulinate synthase by glutethimide and iron: relationship to the synergistic induction of heme oxygenase.

Cable EE, Healey JF, Greene Y, Evans CO, Bonkovsky HL.

Biochim Biophys Acta. 1991 Nov 15;1080(3):245-51.

PMID:
1954232

Supplemental Content

Loading ...
Support Center